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Abstract CD157, a glycosylphosphatidylinositol-anchored pro-
tein, has previously been shown to mediate tyrosine phosphoryla-
tion of a 130 kDa protein (p130) in several cell lines. In this
study, we have identified the p130 protein to be focal adhesion
kinase (FAK or pp125FAK). FAK undergoes phosphorylation at
Tyr-397 and Tyr-861 in intact MCA102 cells stably transfected
with CD157 (MCA/CD157). MCA/CD157 cells, which dis-
played a rounded and compact cell morphology, exhibited a
dispersed distribution, in contrast to a more closely associated
and elongated spindle cell shape in the vector-transfected cells.
MCA/CD157 cells proliferated at a rate 20^25% slower than the
control cells. Our results demonstrate, for the first time, that
FAK is a downstream signalling molecule of CD157. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
CD157/BST-1, a glycosylphosphatidylinositol (GPI)-an-
chored glycoprotein, was ¢rst identi¢ed as an antigen having
increased expression on bone marrow stromal cell lines de-
rived from rheumatoid arthritis patients [1,2]. The deduced
amino acid sequence of CD157 shares about 30% identity
with that of CD38, and both CD157 and CD38 possess
ADP-ribosyl cyclase as well as cyclic ADP ribose (cADPR)
hydrolase activity [3^5]. cADPR has been found to activate
calcium release from intracellular stores via an inositol tris-
phosphate-independent pathway [6].
Increasing evidence suggests that CD157 has a receptor
and/or ligand-like function. CD157, expressed on the bone
marrow stromal cell lines, was found to be responsible for
the augmented growth of a pre-B cell line, DW34 [7]. The
growth support of nurse-like bone marrow cells to the periph-
eral B lymphocytes decreased in the presence of anti-CD157
antibody [8]. Okuyama et al. [9] demonstrated that when
CD157 was cross-linked with an anti-CD157 antibody, a
130 kDa protein (p130) was tyrosine-phosphorylated in
CHO/CD157, U937 and THP-1 cells; a 100 kDa protein
was tyrosine-dephosphorylated in CHO/CD157 cells. In our
previous study, tyrosine phosphorylation of a p130 was also
observed in CHO/CD157, MCA102/CD157 (MCA/CD157),
COS-7/CD157 cells and monocytes (CD157-positive) di¡eren-
tiated from HL-60 cells [10]. The identi¢cation of the p130(s)
seems important to elucidate and understand CD157 function.
In this work, we puri¢ed and sequenced the tyrosine-phos-
phorylated p130 from MCA/CD157 cells. The protein was
identi¢ed to be focal adhesion kinase (FAK or pp125FAK), a
cytoplasmic protein playing key roles in integrating signals
regulating cell functions. We further demonstrated that two
tyrosine residues of FAK, Tyr-397 and Tyr-861, were phos-
phorylated in intact cells. FAK was located at the focal con-
tacts in MCA/vector cells, but was localized to perinuclear
regions in MCA/CD157 cells. The site-speci¢c tyrosine phos-
phorylation of FAK and its alteration in localization might
contribute to the observed changes in cellular morphology
and a reduced proliferation rate of MCA/CD157 cells.
2. Materials and methods
2.1. Materials
The CD157 cDNA was provided by Toshio Hirano, Osaka Univer-
sity Medical Institute, Japan. The MCA102 (mouse ¢brosarcoma) cell
line was obtained from Yunn Hwen Gan from our Department orig-
inally established by others [11]. Monoclonal anti-phosphotyrosine
agarose was purchased from Sigma (St. Louis, MO, USA). Monoclo-
nal anti-phosphotyrosine antibody (PY20) was from PharMingen In-
ternational (San Diego, CA, USA). Polyclonal anti-FAK antibody
(C-20) was obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Polyclonal anti-FAK [pY397], [pY407], [pY576], [pY577],
[pY861], [pY925] antibodies were obtained from Biosource Interna-
tional. Sources of other reagents have been speci¢ed appropriately.
2.2. Cell culture and stable transfection
MCA102 cells were grown in RPMI 1640 medium (Sigma) contain-
ing 10% fetal bovine serum and appropriate L-glutamine, penicillin
and streptomycin supplements (Gibco BRL, Life Technologies). The
full-length coding sequence of human CD157 was inserted into the
multiple cloning sites of vector pXJ41 [12]. The recombinant pXJ41-
CD157 construct was introduced into MCA102 cells using Lipofect-
amine reagent (Gibco BRL) following the protocol of the manufac-
turer. Stable transfectant clones were selected in the culture medium
containing 200 Wg/ml G418 (Sigma). The CD157 expression was an-
alyzed by immunoblotting.
2.3. Tyrosine phosphorylation assay
MCA/vector and MCA/CD157 cells were grown to about 80% con-
£uence. Then cells were incubated in serum-free RPMI 1640 medium
for 45 min and harvested using phosphate-bu¡ered saline (PBS) con-
taining 1.0 mM ethylenediaminetetraacetic acid. After spinning at
200Ug for 5 min, the cellular pellets were resuspended in serum-free
RPMI 1640 at 2U106 cells/ml. An aliquot of 50 Wl of the suspension
was preincubated at 37‡C for 2^3 min and then stimulated with or
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without 10 Wg/ml a⁄nity-puri¢ed polyclonal anti-CD157 antibodies
for 10 min. 1.0 ml ice-cold PBS containing 1.0 mM sodium vanadate
was then added to stop the reaction. The cell suspension was kept on
ice for 5 min. Cells were then lysed in 40 Wl Laemmli sample bu¡er
and boiled for 5 min after being spun down at 1000Ug for 1.0 min.
The tyrosine-phosphorylated proteins were detected by immunoblot-
ting as described below.
2.4. Immunoblotting
Protein samples were subjected to SDS^PAGE and transferred to
nitrocellulose membrane using a semi-dry transelectroblotting system
(Bio-Rad). The membrane was blocked in TBS-T (20 mM Tris, 137
mM NaCl, pH 7.5, 0.1% Tween 20) containing 5% bovine serum
albumin (BSA) for 1 h. After incubating in appropriate primary anti-
body for 1^2 h at room temperature, the membrane was incubated in
horseradish peroxidase-conjugated secondary antibody for 45 min.
The immunoreactive bands were detected by enhanced chemilumines-
cence (ECL) reagent.
2.5. Puri¢cation and sequencing of the tyrosine-phosphorylated p130
MCA/CD157 cells (50U106) were grown to 80% con£uence and
lysed in lysis bu¡er (PBS containing 1% Triton X-100, 0.1 mM phen-
ylmethylsulfonyl £uoride, 10.0 Wg/ml of aprotinin and leupeptin, 50.0
Wg/ml of soybean trypsin inhibitor and 1 mM sodium vanadate) on ice
for 1 h. The lysate was centrifuged at 10 000Ug for 15 min at 4‡C.
Anti-phosphotyrosine agarose beads (30 Wl) were added to the recov-
ered supernatant and binding was allowed to proceed for 3 h at 4‡C
on a rotating platform. The beads were washed three times with the
lysis bu¡er. Laemmli sample bu¡er was added to the beads and boiled
for 5 min before being loaded to SDS^PAGE and stained with Coo-
massie blue or subjected to anti-phosphotyrosine immunoblotting.
The 130 kDa protein band in Coomassie blue-stained gel was excised
for in-gel tryptic digestion followed by peptide sequencing using
MALDI-TOF mass spectrometry.
2.6. Immunoprecipitation
Anti-FAK antibody (10 Wg/ml) was added to the clari¢ed lysate of
10U106 MCA/CD157 and MCA/vector cells, and incubated for 3 h
followed by the addition of 20 Wl protein G agarose and binding was
performed for another 3 h at 4‡C on the rotating platform. After
washing with lysis bu¡er, FAK bound to the beads was probed
with either anti-FAK or anti-phosphotyrosine antibodies.
2.7. Immuno£uorescence analysis
Cells grown on coverslips were ¢xed in 3.7% paraformaldehyde for
15 min at room temperature, and then permeabilized with 0.1% Triton
X-100 in PBS containing 0.5% BSA for 15 min. Coverslips were in-
cubated in blocking bu¡er (3% BSA, 0.01% Triton X-100 in PBS) for
1 h, followed by incubation with 10 Wg/ml anti-FAK antibody and
then FITC-conjugated secondary antibody (1:100) for 1 h. Nuclei
were counterstained with 4.0 Wg/ml propidium iodide for 5 min and
rinsed with bu¡er. Cells were mounted with Vectashield mounting
medium (Vector Laboratories, Burlingame, CA, USA) and sealed
with nail polish. The £uorescence image was analyzed by confocal
microscopy.
2.8. Analysis of cell proliferation
Cells (0.1U106) were seeded in a six well plate and grown in a 37‡C
humidi¢ed incubator with 5% CO2 until reaching V75% con£uence.
Cells were harvested and counted with a hemocytometer. The follow-
ing formula was used to calculate the number of generations:
2n = Nf6Ni, where Nf and Ni were the initial and ¢nal cells counts,
respectively. The doubling time was obtained by dividing the incuba-
tion time by the number of generations.
3. Results
The expression of CD157 in three transfectant clones was
determined by immunoblotting with anti-CD157 antibody
(data not shown). MCA/CD157 cells in all of the analyzed
clones displayed a rounded and compact morphology and
were easily detachable from the culturing £ask, whereas
MCA/vector cells retained a typical ¢broblast spindle shape
and exhibited a strong adherence to the £ask wall (Fig. 1).
Cell proliferation assays showed that the growth rate of
MCA/CD157 clones (doubling time 21.8 h) was 21% slower
than that of MCA/vector clones (doubling time 17.9 h). The
results suggest that CD157 may participate in signalling path-
ways regulating cell morphology and proliferation.
Immunoblotting of cell proteins showed elevated tyrosine
phosphorylation of a 130 kDa protein (p130) in MCA/CD157
cells, and cross-linking of CD157 with polyclonal anti-CD157
antibodies could not further increase the p130 tyrosine phos-
phorylation (Fig. 2). All three MCA/CD157 clones examined
showed similar results (data not shown). The p130 was then
a⁄nity-puri¢ed using anti-phosphotyrosine beads and sub-
jected to tryptic digestion and puri¢cation of peptides. Three
of the recovered peptides were sequenced and the deduced
amino acid sequences were NLLDVIDQAR, AQLSTI-
LEEEK and FFEILSPVYR. A search of the SwissProt pro-
tein database identi¢ed all three sequences to be FAK of
various species including human, mouse, rat, etc. The identity
of p130 as FAK was further con¢rmed by immunoprecipita-
tion with anti-FAK antibodies and immunoblotting with ei-
ther anti-FAK or anti-phosphotyrosine antibodies. Similar
levels of FAK protein were found in MCA/CD157 and
MCA/vector cells, however, the level of tyrosine phosphory-
lation of FAK was much higher in MCA/CD157 cells (Fig. 3).
Multiple tyrosine residues in FAK, including Tyr-397, 407,
576, 577, 861 and 925, have been identi¢ed to undergo auto-
phosphorylation or phosphorylation by Src family kinases
[13,14]. To address the CD157-mediated phosphorylation sites
of FAK, we used phosphorylation state-speci¢c antibodies.
The results of immunoblotting with the di¡erent antibodies
showed that Tyr-397 and Tyr-861 were signi¢cantly phos-
phorylated in MCA/CD157 cells (Fig. 4), while no detectable
phosphorylation was observed for other tyrosine residues,
Tyr-407, 576, 577, and 925 (data not shown). In addition,
immuno£uorescence revealed that FAK localized at the pe-
ripheral focal contacts of MCA/vector cells ; by contrast,
FAK molecules moved away from focal adhesion and located
at the perinuclear region in MCA/CD157 cells (Fig. 5).
Fig. 1. Changes in the morphology of MCA102 cells stably trans-
fected with vector pXJ41 (A and C) and pXJ41-CD157 (B and D).
The morphology of cells was observed at subcon£uent (A and B)
and con£uent (C and D) states. The MCA/vector cells exhibited a
typical elongated spindle cell shape whereas the MCA/CD157 cells
developed a rounded and compact morphology. Bar = 20 Wm.
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4. Discussion
A large number of GPI-anchored proteins have been re-
ported to be able to transduce cellular activation signals,
although they lack transmembrane or cytoplasmic sequences
[15]. Antibody cross-linking of these membrane surface mol-
ecules leads to protein tyrosine phosphorylation, intracellular
calcium mobilization and activation of transcription factors of
cells. The physiological contexts of such activation, however,
remain poorly understood. There are reports that some GPI-
anchored proteins locate at microdomains (also known as
rafts), which are enriched in sphingolipids and cholesterol,
within the cell membrane [16]. It is thought that antibody
cross-linking or overexpression of GPI-anchored proteins
may lead to coalescence of the microdomains, thereby cluster-
ing and activating microdomain-associated Src family protein
tyrosine kinases to phosphorylate the downstream substrates
[16,17]. Urokinase-type plasminogen activator receptor
(uPAR), a GPI-anchored protein, has been shown to associate
with members of the integrin family. FAK was shown to
undergo tyrosine phosphorylation upon binding of uPAR
with its ligand, uPA [18]. In MCA102/CD157 cells, CD157
was not uniformly distributed on the cell surface but was
sporadically distributed in speci¢c regions of the cell surface
membrane, possibly the microdomains (data not shown). The
CD157-mediated FAK phosphorylation was ligand-independ-
ent in MCA/CD157 cells since the cross-linking of CD157
with its antibody could not further increase the phosphoryla-
tion. Time course studies showed that there was not much
change in the level of FAK phosphorylation after the anti-
body was added within a time range of 30 s to 30 min in the
MCA/CD157 clones (data not shown). This might be due to
an overexpression of CD157 molecules on the cell surface
such that these molecules, due to their close proximity on
the cell membrane, could mimic a clustered formation and
were able to transmit signals to downstream molecules. How-
ever, the precise mechanism of how CD157 relays its signal to
FAK remains to be investigated.
FAK is a cytoplasmic tyrosine kinase that can be phosphor-
ylated and activated by many factors [19]. All available infor-
mation suggests that FAK is at a crossroad of multiple signal
pathways, and may play important roles in the assembly of
signalling complexes that regulate diverse cellular functions
including morphogenesis, anchorage, migration, proliferation,
etc. [20,21]. Our observed phenotype alteration and a decrease
in the rate of proliferation in MCA/CD157 cells might be due
to the phosphorylation of FAK. Most evidence so far indi-
cates that FAK phosphorylation is associated with its accu-
mulation at the focal contacts and an increase in cell prolif-
eration [22,23]. Interestingly, our ¢ndings showed that the
CD157-mediated phosphorylation of FAK correlated with
its dispersal from the focal contacts and a decrease in cell
proliferation. The phenotypic di¡erences may be attributed
to a di¡erential phosphorylation of FAK.
FAK has six tyrosine phosphorylation sites that have been
identi¢ed so far: Tyr-397, 407, 576, 577, 861 and 925. Tyr-397
is recognized as the major autophosphorylation site and its
phosphorylation generates a high-a⁄nity site for the SH2 do-
Fig. 3. CD157-dependent tyrosine phosphorylation of FAK in
MCA102 cells. FAK was immunoprecipitated from the lysate of
10U106 MCA/vector (lane 1) and MCA/CD157 (lane 2) cells using
a monoclonal anti-FAK antibody. The immunoprecipitates were im-
munoblotted with either a polyclonal anti-FAK (A) or a monoclo-
nal anti-phosphotyrosine antibody (B). For a similar amount of
protein, FAK was phosphorylated much more in MCA/CD157
cells.
Fig. 4. CD157-mediated tyrosine phosphorylation of Tyr-397 and
861 in intact MCA102 cells. FAK was immunoprecipitated from the
lysate of 10U106 MCA/vector (lane 1) and MCA/CD157 (lane 2)
cells and the immunoprecipitates were immunoblotted with phos-
phorylation state-speci¢c antibodies of FAK, anti-pY397 (A) and
anti-pY861 (B). FAK exhibited an increase in phosphorylation at
Tyr-397 and Tyr-861 in MCA/CD157 cells.
Fig. 2. CD157-mediated tyrosine phosphorylation of p130 in
MCA102 cells. 0.1U106 MCA/vector (lanes 1, 3) and MCA/CD157
(lanes 2, 4) cells were stimulated with (lanes 3, 4) or without (lanes
1, 2) anti-CD157 antibodies for 10 min. Protein tyrosine phosphory-
lation was detected with a monoclonal anti-phosphotyrosine anti-
body. An increase in the tyrosine phosphorylation of p130 was ob-
served in MCA/CD157 cells; cross-linking of CD157 could not
obviously further increase the p130 phosphorylation in MCA/
CD157 cells.
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main of Src family kinases [24]. The interaction of Src with
FAK could lead to the phosphorylation of Tyr-407, 576, 577
and 861, which would further elevate the kinase activity of
FAK in vivo [13,25]. The phosphorylation of Tyr-407, which
is close to Tyr-397 and contains a proline at the +3 position,
may help to recruit additional SH2 domain-containing pro-
teins [26]. Tyr-576 and 577 lie in the catalytic domain and
their phosphorylation is required for the maximum kinase
activity of FAK [25]. The phosphorylation of Tyr-925 creates
a Grb binding site and therefore links FAK to the Ras-mito-
gen-activated protein kinase pathway [27]. In MCA/CD157
cells, we found increased phosphorylation of Tyr-397 and
861 on FAK. The phosphorylated Tyr-861 and its £anking
amino acids (Y861-Q-P-V) may represent a binding site for
SH2 domain-containing proteins and/or regulate the interac-
tion of SH3 domain-containing proteins with the proline-rich
motifs nearby (863^913), thereby regulating signalling path-
ways. The downstream signal transduction mechanism as a
consequence of CD157-dependent FAK phosphorylation at
Tyr-397 and 861 remains to be clari¢ed.
In our previous work, we showed a CD157-dependent p130
tyrosine phosphorylation in several cells lines including CHO/
CD157, COS-7/CD157, MCA/CD157 and monocytes
(CD157-positive) di¡erentiated from HL-60 cells [10]. While
we have shown that the p130 in MCA/CD157 was indeed
FAK, it was determined to be not FAK in other cell lines
(data not shown). This indicates a cell type speci¢city of the
CD157-mediated signalling mechanism. It is possible that dif-
ferent signalling molecules are recruited by CD157 depending
on cell types. However, the questions remain: what are the
identities of the CD157-dependent p130 in other cell lines? Do
the distinct CD157-dependent p130s share a similar signal
transduction mechanism in di¡erent cell lines? The answers
to these questions are essential for further elucidation of
CD157 function in the signalling process. Our results demon-
strate, for the ¢rst time, that FAK is a signal transducer of
CD157 in one type of cell and this ¢nding is likely to pave the
way for further investigations into the function and regulation
of CD157 in normal and diseased cells.
Acknowledgements: This work was supported by National University
of Singapore Research Grant R-183-000-010-112 (to C.F.C.).
References
[1] Itoh, M., Ishihara, K., Tomizawa, H., Kobune, Y., Ishikawa, J.,
Kaisho, T. and Hirano, T. (1994) Biochem. Biophys. Res. Com-
mun. 203, 1309^1317.
[2] Kiasho, T., Ishikawa, J., Oritani, K., Inazawa, J., Tomizawa, H.,
Muraoka, O., Ochi, T. and Hirano, T. (1994) Proc. Natl. Acad.
Sci. USA 91, 5325^5329.
[3] Dong, C., Wang, J., Neame, P. and Cooper, M.D. (1994) Int.
Immunol. 6, 1353^1360.
[4] Howard, M., Grimaldi, J.C., Bazan, J.F., Lund, F.E., Santos-
Argumedo, L., Parkhouse, R.M.E. and Walseth, T.F. (1993) Sci-
ence 261, 352^355.
[5] Hirata, Y., Kimura, N., Sato, K., Ohsugi, Y., Takasawa, S.,
Okamoto, H., Ishikawa, J., Kaisho, T., Ishihara, K. and Hirano,
T. (1994) FEBS Lett. 356, 244^248.
[6] Dargie, P.J., Agre, M.C. and Lee, H.C. (1990) Cell Regul. 1,
279^290.
[7] Kaisho, T., Oritani, K., Ishikawa, J., Tanabe, M., Muraoka, O.,
Ochi, T. and Hirano, T. (1992) J. Immunol. 149, 4088^4095.
[8] Shimaoka, Y., Attrep, J.F., Hirano, T., Ishihara, K., Suzuki, R.,
Toyosaki, T., Ochi, T. and Lipsky, P.E. (1998) J. Clin. Invest.
102, 606^618.
[9] Okuyama, Y., Ishihara, K., Kimura, N., Hirata, Y., Sato, K.,
Itoh, M., Ok, L.B. and Hirano, T. (1996) Biochem. Biophys. Res.
Commun. 228, 838^845.
[10] Hussain, A.M.M. and Chang, C.F. (1999) Cell. Signal. 11, 891^
897.
[11] Shu, S.Y., Chou, T. and Sakai, K. (1989) J. Immunol. 143, 740^
748.
[12] Zheng, X.M., Wang, Y. and Pallen, C.J. (1992) Nature 359, 336^
339.
[13] Calalb, M.B., Zhang, X., Polte, T.R. and Hanks, S.K. (1996)
Biochem. Biophys. Res. Commun. 228, 662^668.
[14] Schlaepfer, D.D. and Hunter, T. (1996) Mol. Cell. Biol. 16, 5623^
5633.
[15] Robinson, P.J. (1991) Immunol. Today 12, 35^41.
[16] Llangumaran, S., He, H. and Hoessli, D.C. (2000) Immunol.
Today 21, 2^7.
[17] Simons, K. and Ikonen, E. (1997) Nature 387, 569^572.
[18] Xue, W., Mizukami, I., Todd, R.F. and Petty, H.R. (1997) Can-
cer Res. 57, 1682^1689.
[19] Ilic, D., Damsky, C.H. and Yamamoto, T. (1997) J. Cell Sci. 110,
401^407.
[20] Risau, W. and Flamme, I. (1995) Annu. Rev. Cell Dev. Biol. 11,
73^91.
[21] Schneider, G.B., Gilmore, A.P., Lohse, D.L., Romer, L.H. and
Burridge, K. (1998) Cell Adhes. Commun. 5, 207^219.
[22] Zhao, J.H., Reiske, H. and Guan, J.L. (1998) J. Cell Biol. 143,
1997^2008.
[23] Cobb, B.S., Schaller, M.D., Leu, T.H. and Parsons, J.T. (1994)
Mol. Cell. Biol. 14, 147^155.
[24] Eide, B.L., Turck, C.W. and Escobedo, J.A. (1995) Mol. Cell.
Biol. 15, 2819^2827.
[25] Calalb, M.B., Polte, T.R. and Hanks, S.K. (1995) Mol. Cell.
Biol. 15, 954^963.
[26] Cantley, L.C. and Songyang, Z. (1994) J. Cell Sci. 18 (Suppl.),
121^126.
[27] Schlaepfer, D.D., Hanks, S.K., Hunter, T. and Van der Geer, P.
(1995) Nature 372, 786^791.
Fig. 5. Immuno£uorescence of FAK (green) and staining of nuclei
with propidium iodide (red) in MCA/vector (A) and MCA/CD157
(C) cells. B and D: Phase contrast photomicrographs of the cells in
A and C, respectively. FAK was localized predominantly at the fo-
cal contacts in MCA/vector cells, but was localized at the perinu-
clear region in MCA/CD157 cells. Bar = 5 Wm.
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